EUVIMEDDescobrir EUVIMED
Crossref

Appendiceal neuroendocrine tumours, when to operate?

Imogen Watt iD, Luke Henry iD, Jamish Gandhi, Braden Woodhouse iD, Ben Lawrence

Colorectal Disease · 2025

DOI: 10.1111/codi.70239 ↗

At a glance

Journal article in Colorectal Disease, 2025. Written by Imogen Watt and 4 co-authors. Institution: Auckland City Hospital, Auckland, New Zealand. Major MEDLINE topics: Appendiceal Neoplasms, Neuroendocrine Tumors, Appendectomy, Colectomy. Cited 1 times so far (Crossref); 29 references.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Introduction

Appendix neuroendocrine tumours (ANETs) carry variable risk depending on histopathological risk factors. Completion right hemicolectomy (RH) is recommended for tumours over 2 cm, with those under 1 cm considered cured by appendectomy. Evidence for RH in ANETs between 1 and 2 cm is unclear.

Aim

To determine if a non‐surgical approach is appropriate for patients with well‐differentiated 1–2 cm ANETs, alongside reviewing outcomes for under 1 cm and over 2 cm tumours.

Methods

A retrospective cohort study of all ANETs resected by index appendicectomy in Auckland between 1995 and 2012, using the New Zealand NETwork! registry.

Results

Two hundred and four patients with ANETs met inclusion criteria; 157 under 1 cm (77%), 40 between 1 and 2 cm (20%), 7 over 2 cm (3.4%). RH was performed in 20 patients, seven in the under 1 cm cohort, 9 in the 1–2 cm cohort and 4 in the over 2 cm cohort. One patient with an over 2 cm ANET had subsequent RH histology demonstrating lymph node metastasis. Follow‐up was radiological, median follow‐up 62 months (range 2–204). Eight 1–2 cm ANETs had histological risk factors but did not undergo RH and had no evidence of recurrence or metastasis on follow‐up. No patients died from their ANET.

Conclusion

Patients' with ANETs under 2 cm did not exhibit metastases. Our data support RH in patients' with ANETs over 2 cm and a more conservative approach in those under 2 cm.

Subjects

MeSH terms (MEDLINE)

Appendiceal NeoplasmsNeuroendocrine TumorsAppendectomyColectomyHumansRetrospective StudiesMaleFemaleMiddle AgedAgedAdultNew ZealandTumor BurdenAged, 80 and overTreatment OutcomeRisk FactorsRegistries

Author keywords

NETappendiceal NENappendiceal cancerappendiceal neuroendocrine neoplasmappendiceal neuroendocrine tumoursappendicitisappendixappendix cancerneuroendocrine neoplasmneuroendocrine tumour

Authors and institutions

  • Auckland City Hospital, Auckland, New Zealand.
  • The University of Auckland, Auckland, New Zealand.

ORCID profiles: Imogen Watt, Luke Henry, Braden Woodhouse

Cite

APA

Watt, I., Henry, L., Gandhi, J., Woodhouse, B., & Lawrence, B. (2025). Appendiceal neuroendocrine tumours, when to operate?. Colorectal Disease. https://doi.org/10.1111/codi.70239

Vancouver

Watt I, Henry L, Gandhi J, Woodhouse B, Lawrence B. Appendiceal neuroendocrine tumours, when to operate?. Colorectal Disease. 2025. doi:10.1111/codi.70239

BibTeX
@article{Watt2025,
  author = {Watt, Imogen and Henry, Luke and Gandhi, Jamish and Woodhouse, Braden and Lawrence, Ben},
  title = {Appendiceal neuroendocrine tumours, when to operate?},
  journal = {Colorectal Disease},
  year = {2025},
  doi = {10.1111/codi.70239}
}
Start for free →